• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches".

作者信息

Buti Sebastiano, Leonetti Alessandro, Lattanzi Elisabetta, D'Abbiero Nunziata, Bersanelli Melissa

机构信息

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

Radiotherapy Unit, University Hospital of Parma, Parma, Italy.

出版信息

Ann Transl Med. 2019 Jul;7(Suppl 3):S106. doi: 10.21037/atm.2019.05.04.

DOI:10.21037/atm.2019.05.04
PMID:31576313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6685901/
Abstract
摘要

相似文献

1
Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches".立体定向体部放射治疗在肾细胞癌治疗中的作用：在“资源丰富的困境”时代进行个体化治疗
Ann Transl Med. 2019 Jul;7(Suppl 3):S106. doi: 10.21037/atm.2019.05.04.
2
Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.经立体定向放射治疗的肾细胞癌，尸检证实有组织学改变：一例报告
BMC Res Notes. 2014 Apr 26;7:270. doi: 10.1186/1756-0500-7-270.
3
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.立体定向体部放疗在寡转移肾细胞癌治疗中的作用。
J Urol. 2019 Jan;201(1):70-76. doi: 10.1016/j.juro.2018.08.049.
4
Treatment options in metastatic renal carcinoma: an embarrassment of riches.转移性肾癌的治疗选择：选择过多令人为难。
J Clin Oncol. 2006 Jan 1;24(1):1-3. doi: 10.1200/JCO.2005.03.7234. Epub 2005 Dec 5.
5
Cardioprotection with Yet Another SGLT2 Inhibitor - An Embarrassment of Riches.
N Engl J Med. 2021 Jan 14;384(2):179-181. doi: 10.1056/NEJMe2033176.
6
Rectal cancer treatment: an embarrassment of riches?
ANZ J Surg. 2023 Oct;93(10):2293-2294. doi: 10.1111/ans.18634. Epub 2023 Jul 28.
7
Editorial overview: An embarrassment of riches.编辑概述：财富过剩带来的尴尬。
Curr Opin Plant Biol. 2021 Aug;62:102105. doi: 10.1016/j.pbi.2021.102105.
8
An embarrassment of riches? Mechanisms underlying VCP neurodegeneration.财富过多带来的尴尬？VCP神经变性的潜在机制。
Brain. 2023 Jun 1;146(6):2199-2200. doi: 10.1093/brain/awad140.
9
Society of Interventional Radiology 2023 Charles T. Dotter Lecture: "IR 2023: The Embarrassment of Riches".
J Vasc Interv Radiol. 2024 Jan;35(1):1-6. doi: 10.1016/j.jvir.2023.09.033.
10
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.立体定向体部放疗在寡转移肾细胞癌治疗中的作用。
J Urol. 2019 Jan;201(1):70-75. doi: 10.1016/j.juro.2018.08.049.

本文引用的文献

1
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.肾细胞癌并非抗拒放疗：立体定向体部放疗后肿瘤缓慢但持续缩小。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033818822329. doi: 10.1177/1533033818822329.
2
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.阿维鲁单抗联合阿昔替尼与舒尼替尼治疗晚期肾细胞癌。
N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16.
3
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.派姆单抗联合阿昔替尼对比舒尼替尼用于晚期肾细胞癌。
N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16.
4
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma.立体定向体部放疗在寡转移肾细胞癌治疗中的作用。
J Urol. 2019 Jan;201(1):70-75. doi: 10.1016/j.juro.2018.08.049.
5
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.纳武利尤单抗联合伊匹木单抗与舒尼替尼治疗晚期肾细胞癌的比较
N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.
6
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".立体定向体部放疗用于肾细胞癌肺转移——德国“立体定向放疗”工作组的多中心分析
J Thorac Dis. 2017 Nov;9(11):4512-4522. doi: 10.21037/jtd.2017.10.108.
7
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.立体定向消融放疗用于肾细胞癌颅外转移的安全性和有效性
Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):91-100. doi: 10.1016/j.ijrobp.2017.01.032.
8
Systemic Therapy for Metastatic Renal-Cell Carcinoma.转移性肾细胞癌的全身治疗
N Engl J Med. 2017 Jan 26;376(4):354-366. doi: 10.1056/NEJMra1601333.
9
Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03).舒尼替尼与放射治疗联合用于软组织肉瘤的术前治疗：德国跨学科肉瘤组（GISG-03）I期试验结果
Radiat Oncol. 2016 Jun 3;11:77. doi: 10.1186/s13014-016-0654-2.
10
Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).立体定向体部放射治疗（SBRT）对转移性肾细胞癌（RCC）的胸部、腹部及软组织病灶的局部控制率
Radiat Oncol. 2015 Oct 28;10:218. doi: 10.1186/s13014-015-0528-z.